Early identification of cognitive impairment in the ophtalmology - a feasibility study to integrate ophtalmology in the routine identification of people with dementia during a routine OTC-assessment

Early identification of cognitive impairment in the ophtalmology - a feasibility study to integrate ophtalmology in the routine identification of people with dementia during a routine OTC-assessment - FrühDiA

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00026971

Enrollment

Registered

2021-11-08

Start date

2021-11-15

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

F00 F01 F02 F03 F04 F06.7

Interventions

Group 1: Patients at the ophtalmology clinics that undergo routine OCT-assessment will be asked for participation in the study. Upon giving written informed consent they will undergo a semi-structured

Eligibility

Sex/Gender

All

Age

65 Years to No maximum

Inclusion criteria

Inclusion criteria: Routine OCT-assessment during routine visit at the ophtalmologist, sufficient language skills

Exclusion criteria

Exclusion criteria: Glaucoma, advanced cataract, diabetic retinopathy/ Makulopathy, Assessment not applicable (according to the treating physician)

Design outcomes

Primary

Measure	Time frame
How big is the proportion of people with cognitive impairments identified during routine OCT-assessment?	—

Secondary

Measure	Time frame
How many patients participate in a cognitive screening? How many people do show cognitive impairment and lower thickness of the retina? How many people do have a cognitive impairment, a thinner retina AND a formal diagnosis of dementia? How many people get a guideline-oriented diagnostic of cognitive impairment afterwards? What other factors are associated with the biomarker, the cognitive status and the formal diagnosis of dementia?	—

Measure

Time frame

How many patients participate in a cognitive screening? How many people do show cognitive impairment and lower thickness of the retina? How many people do have a cognitive impairment, a thinner retina AND a formal diagnosis of dementia? How many people get a guideline-oriented diagnostic of cognitive impairment afterwards? What other factors are associated with the biomarker, the cognitive status and the formal diagnosis of dementia?

—

Countries

Germany

Contacts

Public ContactGreta Otto

Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE)

s-grotto@uni-greifswald.de03834 86 7593

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026